Across TCGA pan-cancer cohorts, LINC01164 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of LINC01164’s most consistent transcriptional readouts.
The strongest signal is observed in rectum adenocarcinoma (READ), where LINC01164 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01164 is over-expressed in tumor.
READ, LIHC, and LUSC are the cancer types where LINC01164 tumor–normal differential expression is most reproducible.